Actively Recruiting
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
Led by Oregon Health and Science University · Updated on 2025-01-14
100
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to use mass spectrometry techniques to analyze exhaled patient breath in non-COVID ICU-admitted patients requiring ventilation for a rapid and accurate early detection of pulmonary diseases and inflammatory markers.
CONDITIONS
Official Title
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Non-COVID-19 adult consented patients (>18 years old) on ventilatory support in the ICU at OHSU
You will not qualify if you...
- Patients with severe respiratory distress defined by arterial pO2 <60 mmHg on maximal FiO2 and optimal ventilator settings
- Patients with severe hemodynamic instability defined by receiving IV infusion of two or more pressors or inotropic medications and mean arterial pressure <60 mmHg or systolic blood pressure <80 mmHg
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oregon Health and Science University
Portland, Oregon, United States, 97239
Actively Recruiting
Research Team
L
Laura H Nguyen, B.S.
CONTACT
A
Albert Chi, M.D., F.A.C.S
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here